Trial intelligence / Profile preview

Fuyanle Capsules in Vulvovaginal Candidiasis

CTR20140647Phase 3Active

Sponsor
Fangsheng Pharmaceutical
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Fuyanle in vulvovaginal candidiasis (VVC), sponsored by Fangsheng Pharmaceutical. Started Oct 2014; status: active.

02

Drugs

Fuyanle
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on CTR20140647.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140647.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call